TipRanks
Go Ultimate55% OFF

Oncologix Tech (OCLG) Financial Statements

Oncologix Tech Financial Overview

Oncologix Tech's market cap is currently $1.66K. The company's EPS TTM is $0.00; its P/E ratio is -0.03; Oncologix Tech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Aug 17
Income Statement
Total Revenue$ 2.85M
Gross Profit$ 571.56K
Operating Income$ -865.00K
EBITDA$ -1.11M
Net Income$ -2.37M
Balance Sheet
Cash & Short-Term Investments$ 30.83K
Total Assets$ 1.50M
Total Debt$ 5.16M
Net Debt$ 5.12M
Total Liabilities$ 7.47M
Stockholders' Equity$ -5.97M
Cash Flow
Free Cash Flow$ -25.12K
Operating Cash Flow$ -24.20K
Investing Cash Flow$ -913.00
Financing Cash Flow$ -4.24K

Currency in USD

Oncologix Tech Earnings and Revenue History

-3M03M6M-85 %-84 %-83 %-82 %EarningsProfit Margin2017RevenueEarningsProfit Margin

Oncologix Tech Debt to Assets

03M6M9M498 %499 %500 %501 %LiabilitiesDebt to Assets2017AssetsLiabilitiesDebt to Assets

Oncologix Tech Cash Flow

-30K-25K-20K-15K-10K-5K02017OperatingInvestingFinancing

Oncologix Tech Forecast EPS vs Actual EPS